Titel

Merkliste
1 Ergebnisse

Extended follow-up of a phase 2 trial of xevinapant plus ch..:

Tao, Y ; Sun, X.S ; Pointreau, Y...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2022.12.015. , 2023

Link: https://serval.unil.ch/notice/serval:BIB_4F4CBA34EB3A

RT Journal
T1 <Title>Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivlausanne:oai:serval.unil.ch:BIB_4F4CBA34EB3A&Exemplar=1&LAN=DE
				
A1 Tao, Y
A1 Sun, X.S
A1 Pointreau, Y
A1 Le Tourneau, C
A1 Sire, C
A1 Kaminsky, M.C
A1 Coutte, A
A1 Alfonsi, M
A1 Calderon, B
A1 Boisselier, P
A1 Martin, L
A1 Miroir, J
A1 Ramee, J.F
A1 Delord, J.P
A1 Clatot, F
A1 Rolland, F
A1 Villa, J
A1 Magne, N
A1 Elicin, O
A1 Gherga, E
A1 Nguyen, F
A1 Lafond, C
A1 Bera, G
A1 Calugaru, V
A1 Geoffrois, L
A1 Chauffert, B
A1 Damstrup, L
A1 Crompton, P
A1 Ennaji, A
A1 Gollmer, K
A1 Nauwelaerts, H
A1 Bourhis, J
YR 2023
K1 Humans
K1 Squamous Cell Carcinoma of Head and Neck/drug therapy
K1 Head and Neck Neoplasms/drug therapy
K1 Follow-Up Studies
K1 Antineoplastic Agents/therapeutic use
K1 Cisplatin
K1 Chemoradiotherapy/adverse effects
K1 Chemoradiotherapy/methods
K1 Antineoplastic Combined Chemotherapy Protocols/adverse effects
K1 Chemoradiotherapy
K1 Efficacy
K1 Locally advanced squamous cell carcinoma of the head and neck
K1 Survival
K1 Xevinapant
JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2022.12.015
LK http://dx.doi.org/https://serval.unil.ch/notice/serval:BIB_4F4CBA34EB3A
DO https://serval.unil.ch/notice/serval:BIB_4F4CBA34EB3A
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)